Clinical Trials Directory

Trials / Completed

CompletedNCT00888602

Study to Evaluate the Effects of Psyllium on Blood Glucose

An Open Label, Randomized, 4-Period Cross-over Study to Evaluate the Effects of Psyllium Taken Before a Meal on Postprandial Blood Glucose in Healthy Males

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Procter and Gamble · Industry
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This is an open label, single use, randomized, 4-period cross-over study. In each period, subjects will receive one of 4 test combinations. Blood will be drawn prior to study product consumption and following study product consumption for glucose measures.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT3.4 g psyllium3.4 g psyllium served with meal
DIETARY_SUPPLEMENT6.8 g psyllium6.8 g psyllium served with a meal
DIETARY_SUPPLEMENT6.8 g psyllium6.8 g psyllium
OTHERMealmeal

Timeline

Start date
2009-04-01
Primary completion
2009-05-01
Completion
2009-05-01
First posted
2009-04-27
Last updated
2012-12-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00888602. Inclusion in this directory is not an endorsement.

Study to Evaluate the Effects of Psyllium on Blood Glucose (NCT00888602) · Clinical Trials Directory